Thus, we thought Bcat1−/− NOTCH1-T tumors could manifest distinct metabolic features to Bcat1+/+ NOTCH1-T tumors, somewhat mimicking metabolic heterogeneity found in human disease and may be an interesting model to include to evaluate our metabolic classifier for leukemia. This evidence concerns the gene BCAT1 and leukemia.